$GWPH to Present at the 28th Annual Piper Jaffray Healthcare Conference

GW Pharmaceuticals to Present at the 28th Annual Piper Jaffray Healthcare Conference…

$GWPH Announces Second Positive Phase 3 Pivotal Trial for Epidiolex®

GW Pharmaceuticals Announces Second Positive Phase 3 Pivotal Trial for Epidiolex® (cannabidiol)…

$GWPH To Present At Investor Conferences

GW Pharmaceuticals to Present at Two Upcoming Investor Conferences LONDON, Sept. 10,…